Company / Cost of Revenue
Co-Diagnostics, Inc. Cost of Revenue History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$222.4K
FY2025
5-year range
$222.4K / $16.6M
FY2021-FY2025
Trend
-77.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cost of Revenue has declined for 4 consecutive years, from $17M in FY2021 to $222,377 in FY2025.
Based on SEC 10-K filings.
$222,377 in FY2025 with a 5-year CAGR of +14.6%.
Improved from $4M to $222,377 over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -73.2%
- 5-Year CAGR
- +14.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- Co-Diagnostics, Inc.'s cost of revenue has declined for 4 consecutive years.
- 5-year CAGR of +14.6%, indicating consistent growth.
- In FY2025, cost of revenue decreased 77.7% year-over-year.
- Peak cost of revenue was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $222.4K | -77.7% |
| FY2024 | $999.1K | -76.1% |
| FY2023 | $4.2M | -63.8% |
| FY2022 | $11.6M | -30.2% |
| FY2021 | $16.6M | +14656.9% |
| FY2020 | $112.4K | +1097.2% |
| FY2019 | $9.4K | +3009.6% |
| FY2018 | $302 | +0.0% |
| FY2017 | $302 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026